Answers are grounded in this paper and cite their sources.
Methotrexate (MTX) is a metabolite that functions as an antifolate, impeding DNA synthesis, repair, and cell replication.Its clinical uses include rheumatoid arthritis treatment and cancer treatments due to its anti-folate mechanism of action.This medication serves as the primary disease-modifying antirheumatic drug (DMARD) for individuals afflicted with dermatological, inflammatory, and autoimmune conditions.Methotrexate has a unique mode of action, both in terms of its usage as a chemotherapeutic drug and as an immunosuppressant, in the management of autoimmune disorders.It can be combined with anti-TNF (Tumour Necrosis Factor) drugs and used as an off-label treatment for graft-versus-host disease.However, there are limitations to its usage, such as increased toxicity problems and brief plasma life.Methotrexate can be used as a nano-drug to decrease administration frequency while maximizing pharmacological effects and minimizing systemic side effects.The utilization of nanodrugs has been found to be more efficacious in comparison to intra-articular or oral delivery methods.Additionally, it has been determined that the co-loading of MTX-SPIONs (Superparamagnetic iron oxide nanoparticles) in NLC (Nanostructured lipid carriers) has been found to be a viable carrier for the delivery of MTX.The present review focuses on potential effects of methotrexate on health.
No takes yet. Share an insight, caveat, or question.
Payal et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: